In the context of neurodegenerative pathologies, SUMO1 overexpression leads to increased amyloid plaque density, increased dendritic spine loss, and more severe cognitive deficits in a mouse model of AD [73] and impairment of synaptic function associated with memory impairment [91]. The gene discussed is SUMO1; the disease is Cognitive impairment.